Literature DB >> 1314564

Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.

C A Lingwood1, S K Yiu.   

Abstract

Previous studies have implicated the glycolipid receptor for the Escherichia coli-derived verotoxin, globotriaosylceramide (Gb3; Gal alpha 1-4Gal beta 1-4Glc-ceramide), in the mechanism of alpha 2 interferon signal transduction. Comparison of the amino acid sequence of the human alpha 2 interferon receptor with that of the B (receptor-binding)-subunit of verotoxin shows three regions of similarity which may provide a structural basis for alpha 2-interferon-receptor/Gb3 interaction.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1314564      PMCID： PMC1130985          DOI： 10.1042/bj2830025

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  24 in total

1.  Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.

Authors:  T Waddell; A Cohen; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Interaction of Shigella toxin with globotriaosyl ceramide receptor-containing membranes: a fluorescence study.

Authors:  W K Surewicz; K Surewicz; H H Mantsch; F Auclair
Journal:  Biochem Biophys Res Commun       Date:  1989-04-14       Impact factor: 3.575

3.  Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor.

Authors:  A Cohen; G E Hannigan; B R Williams; C A Lingwood
Journal:  J Biol Chem       Date:  1987-12-15       Impact factor: 5.157

Review 4.  Interferons and their actions.

Authors:  S Pestka; J A Langer; K C Zoon; C E Samuel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Interferon-gamma alters expression of endothelial cell-surface glycosphingolipids.

Authors:  B K Gillard; M A Jones; A A Turner; D E Lewis; D M Marcus
Journal:  Arch Biochem Biophys       Date:  1990-05-15       Impact factor: 4.013

6.  Serological differences between verocytotoxin 2 and shiga-like toxin II.

Authors:  S C Head; M A Karmali; M E Roscoe; M Petric; N A Strockbine; I K Wachsmuth
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

7.  Dysentery in pigs associated with cystic enlargement of submucosal glands in the large intestine.

Authors:  H W Ferguson; S D Neill; G R Pearson
Journal:  Can J Comp Med       Date:  1980-04

8.  Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA.

Authors:  G Uzé; G Lutfalla; I Gresser
Journal:  Cell       Date:  1990-01-26       Impact factor: 41.582

9.  Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome.

Authors:  H Ito; A Terai; H Kurazono; Y Takeda; M Nishibuchi
Journal:  Microb Pathog       Date:  1990-01       Impact factor: 3.738

10.  Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease.

Authors:  A Cohen; V Madrid-Marina; Z Estrov; M H Freedman; C A Lingwood; H M Dosch
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823
View more
  8 in total

1.  Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells.

Authors:  S Arab; M Murakami; P Dirks; B Boyd; S L Hubbard; C A Lingwood; J T Rutka
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

Review 2.  Aglycone modulation of glycolipid receptor function.

Authors:  C A Lingwood
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.

Authors:  M D Maloney; B Binnington-Boyd; C A Lingwood
Journal:  Glycoconj J       Date:  1999-12       Impact factor: 2.916

4.  The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1.

Authors:  H Farkas-Himsley; R Hill; B Rosen; S Arab; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

5.  Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells.

Authors:  J White; L Johannes; F Mallard; A Girod; S Grill; S Reinsch; P Keller; B Tzschaschel; A Echard; B Goud; E H Stelzer
Journal:  J Cell Biol       Date:  1999-11-15       Impact factor: 10.539

6.  CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.

Authors:  M D Maloney; C A Lingwood
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

Review 7.  Molecular Biology of Escherichia Coli Shiga Toxins' Effects on Mammalian Cells.

Authors:  Christian Menge
Journal:  Toxins (Basel)       Date:  2020-05-23       Impact factor: 4.546

Review 8.  Role of Globotriaosylceramide in Physiology and Pathology.

Authors:  Ana Beatriz Celi; Jorge Goldstein; María Victoria Rosato-Siri; Alipio Pinto
Journal:  Front Mol Biosci       Date:  2022-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.